Indication
Apealea in combination with carboplatin is indicated for the treatment of adult patients with first relapse of platinum?sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.
Loading your page…
Loading your page…
Ovarian Neoplasms
Marketing Authorisation Holder: Inceptua AB
EMA Authorisation: 20/11/2018
INN: paclitaxel
AI Drug & Interaction Analysis
Free account required
Ask Osler about Apealea: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.